– NASDAQ:AMRN

stock price today

$16.1
+15.65
+3493.75%
Financial Health
0
1
2
3
4
5
6
7
8
9

stock price monthly change

-42.62%
month

stock price quarterly change

-42.62%
quarter

stock price yearly change

-50.23%
year

key metrics

Market Cap
 189.05M
Enterprise value
 359.62M
P/E
 -5.46
EV/Sales
 0.97
EV/EBITDA
 -3.67
Price/Sales
 1.53
Price/Book
 0.95
PEG ratio
 N/A
EPS
 -0.12
Revenue
 278.07M
EBITDA
 -39.17M
Income
 -52.64M
Revenue Q/Q
 -34.29%
Revenue Y/Y
 -22.87%
Profit margin
 -28.66%
Oper. margin
 -25.01%
Gross margin
 65.68%
EBIT margin
 -25.01%
EBITDA margin
 -14.09%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

stock price history

stock forecast

financial statements

Profit Margin

(NASDAQ:AMRN): Profit margin
Jun 2023 80.16M -17.56M -21.9%
Sep 2023 66.05M -19.31M -29.23%
Dec 2023 75.36M -5.83M -7.74%
Mar 2024 56.48M -9.94M -17.61%
AMRN income statement history

Financials Estimate

(NASDAQ:AMRN): Analyst Estimates
2025 214.85M -64.91M -30.21%
2026 270.59M -15.77M -5.83%
2027 328.7M 2.03M 0.62%
2028 546.7M 118.21M 21.62%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Quarterly Earnings

(NASDAQ:AMRN): Earnings per share (EPS)
2022-10-27 0.00345 0.02
2022-12-31 0.00142 0.00213
2023-03-01 0.00796 0.02
AMRN earnings history

Debt to Assets

(NASDAQ:AMRN): Debt to assets
Jun 2023 860018000 290.89M 33.82%
Sep 2023 839031000 285.88M 34.07%
Dec 2023 831684000 279.58M 33.62%
Mar 2024 790013000 244.07M 30.9%
AMRN balance sheet history

Cash Flow

(NASDAQ:AMRN): Cash Flow
Jun 2023 7.20M 34.32M 60K
Sep 2023 7.32M 30.76M -277K
Dec 2023 -651.56K -71.29M 83K
Mar 2024 -12.59M 28.70M -1.42M
AMRN cash flow history

alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions


Employees

(NASDAQ:AMRN): Employee count
Aug 2023 365
Sep 2023 365
Oct 2023 365
Nov 2023 365
Dec 2023 365
Jan 2024 365
Feb 2024 365
Mar 2024 275
Apr 2024 275
May 2024 275
Jun 2024 275
Jul 2024 275

other data


Hedge Funds Holdings Q1 2022

32.84% -1.34%
of AMRN is owned by hedge funds
211 -13
hedge funds hold AMRN stock
132.18M -3.39M
shares is hold by hedge funds
AMRN hedge funds holdings changes


Insider Trading

(NASDAQ:AMRN): Insider trades (number of shares)
Period Buy Sel
Aug 2023 300000 0
Dec 2023 0 34131
Jan 2024 14426 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
REILLY THOMAS CHARLES officer: EVP and .. Ordinary Shares 33,333 N/A N/A
Option
REILLY THOMAS CHARLES officer: EVP and .. Restricted Stock Unit 33,333 N/A N/A
Option
BERG AARON officer: EVP, Pre.. Ordinary Shares 44,933 N/A N/A
Option
BERG AARON officer: EVP, Pre.. Ordinary Shares 34,567 N/A N/A
Option
BERG AARON officer: EVP, Pre.. Restricted Stock Unit 44,933 N/A N/A
Option
BERG AARON officer: EVP, Pre.. Restricted Stock Unit 34,567 N/A N/A
Option
KETCHUM STEVEN B officer: Chief Sc.. Ordinary Shares 44,933 N/A N/A
Option
KETCHUM STEVEN B officer: Chief Sc.. Ordinary Shares 34,567 N/A N/A
Option
KETCHUM STEVEN B officer: Chief Sc.. Restricted Stock Unit 44,933 N/A N/A
Option
KETCHUM STEVEN B officer: Chief Sc.. Restricted Stock Unit 34,567 N/A N/A
AMRN insider trading transactions


Earnings Call Transcripts

Quarter Transcript
Q1 2024 1 May 2024 Q1 2024 Earnings Call Transcript
Q4 2023 29 Feb 2024 Q4 2023 Earnings Call Transcript
Q3 2023 1 Nov 2023 Q3 2023 Earnings Call Transcript
Q1 2023 3 May 2023 Q1 2023 Earnings Call Transcript
AMRN earnings call transcripts


Latest News

Monday, 16 December 2024
globenewswire.com
Friday, 13 December 2024
globenewswire.com
Tuesday, 19 November 2024
zacks.com
Thursday, 31 October 2024
zacks.com
Wednesday, 30 October 2024
seekingalpha.com
Monday, 9 September 2024
globenewswire.com
Thursday, 22 August 2024
globenewswire.com
Thursday, 1 August 2024
zacks.com
Wednesday, 31 July 2024
seekingalpha.com
globenewswire.com
Monday, 29 July 2024
investorplace.com
Wednesday, 17 July 2024
globenewswire.com
globenewswire.com
Monday, 8 July 2024
globenewswire.com
Friday, 7 June 2024
globenewswire.com
Tuesday, 4 June 2024
globenewswire.com
Tuesday, 28 May 2024
globenewswire.com
Monday, 6 May 2024
globenewswire.com
Friday, 3 May 2024
Zacks Investment Research
Wednesday, 1 May 2024
Zacks Investment Research
Monday, 15 April 2024
GlobeNewsWire
Thursday, 4 April 2024
Zacks Investment Research
Wednesday, 3 April 2024
The Motley Fool
Friday, 1 March 2024
Zacks Investment Research
Thursday, 29 February 2024
Seeking Alpha
Thursday, 15 February 2024
GlobeNewsWire
Zacks Investment Research
Monday, 15 January 2024
Seeking Alpha
Friday, 12 January 2024
Zacks Investment Research
Thursday, 11 January 2024
Zacks Investment Research

Ideas & Opinions

Frequently Asked Questions (FAQ)

  • What's the price of stock today?

    One share of  stock can currently be purchased for approximately $16.1.

  • When is 's next earnings date?

    Unfortunately, 's (AMRN) next earnings date is currently unknown.

  • Does pay dividends?

    No, does not pay dividends.

  • How much money does make?

    has a market capitalization of 189.05M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 16.87% to 306.91M US dollars. made a loss 59.11M US dollars in net income (profit) last year or $0.02 on an earnings per share basis.

  • What is 's stock symbol?

    null is traded on the NASDAQ under the ticker symbol "AMRN".

  • What is 's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of ?

    Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are 's key executives?

    's management team includes the following people:

    • Dr. Steven B. Ketchum Pres of R&D, Senior Vice President and Chief Scientific Officer(age: 60, pay: $758,140)
    • Mr. Michael W. Kalb Chief Financial Officer, Senior Vice President & Assistant Sec.(age: 54, pay: $656,660)
    • Mr. Aaron D. Berg Executive Vice President & Pres of U.S.(age: 62, pay: $656,090)

  • How many employees does have?

    As Jul 2024, employs 275 workers.

  • When went public?

    null is publicly traded company for more then 32 years since IPO on 1 Apr 1993.

  • What is 's official website?

    The official website for is amarincorp.com.

  • How can i contact ?

    can be reached via phone at +353 1 669 9020.

company profile:

Exchange:

NASDAQ

Full time employees:

275

Industry:

Biotechnology

Sector:

Healthcare

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

+353 1 669 9020
Grand Canal Docklands
Dublin, 2

CIK: 0000897448
ISIN: US0231112063
CUSIP: 023111206